Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

APPLIED THERAPEUTICS, INC.

(APLT)
  Rapporto
Tempo differito Nasdaq  -  21:07:16 08/02/2023
1.081 USD   -3.48%
04/01Applied Therapeutics, Inc. stipula un accordo di licenza e fornitura esclusiva con Mercury Pharma Group Limited
CI
04/01Aggiornamento settoriale: i titoli del settore sanitario sono fermi prima del mercato di mercoledì
MT
04/01Applied Therapeutics si allea con Advanz Pharma per la commercializzazione del farmaco per i disturbi neurologici in Europa
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivatiFondi 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su APPLIED THERAPEUTICS, INC.
05/01ADVANZ PHARMA to receive exclusive rights from Applied Therapeutics to commercialise AT..
04/01Applied Therapeutics Inc.: Entry into a Material Definitive Agreement (form 8-K)
04/01Applied Therapeutics, Inc. Enters in to Exclusive License and Supply Agreement with Mer..
04/01Sector Update: Health Care Stocks Steady Premarket Wednesday
04/01Applied Therapeutics Teams Up With Advanz Pharma for Commercialization of Neurological ..
04/01Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of ..
04/01Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of ..
04/01Applied Therapeutics, Inc. Announces Partnership with Advanz Pharma for Commercializati..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing ..
2022APPLIED THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition ..
2022Applied Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
2022Applied Therapeutics Reports Third Quarter 2022 Financial Results
2022Applied Therapeutics Reports Third Quarter 2022 Financial Results
2022Applied Therapeutics: APLT Corporate Overview – November 2022
2022Applied Therapeutics Announces Multiple Data Presentations at the American Heart Associ..
2022Applied Therapeutics Announces Multiple Data Presentations at the American Heart Associ..
2022Applied Therapeutics Announces Multiple Data Presentations at the American Heart Associ..
2022Applied Therapeutics, Inc. Announces Multiple Data Presentations At the American Heart ..
2022Applied Therapeutics Inc.: Amendments to Articles of Inc. or Bylaws; Change in Fiscal Yea..
2022Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF T..
2022Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF T..
2022Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF T..
2022Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids P..
2022Sector Update: Health Care Stocks Sputtering into Thursday Close
2022Top Midday Decliners
2022Sector Update: Health Care Stocks Sliding in Weak Thursday Market
2022Sector Update: Health Care
2022Wall Street Set to Open Lower as Jobless Claims Rise
2022Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids P..
2022Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids P..
2022Applied Therapeutics, Inc. Announces Positive Data Trend in AT-007 Action-Galactosemia ..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Certain Pre Funded Warrants of Applied Therapeutics, Inc. are subject to a Lock-Up Agre..
2022Certain Warrants of Applied Therapeutics, Inc. are subject to a Lock-Up Agreement Endin..
2022Certain Common Stock of Applied Therapeutics, Inc. are subject to a Lock-Up Agreement E..
2022Applied Therapeutics Reports Second Quarter 2022 Financial Results
2022APPLIED THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition ..
2022Applied Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Mont..
2022Applied Therapeutics: Reports Second Quarter 2022 Financial Results - Form 8-K
2022Applied Therapeutics Reports Second Quarter 2022 Financial Results
2022Applied Therapeutics: Material Event - Form 8-K
2022Applied Therapeutics Inc.: Other Events (form 8-K)
2022Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Confere..
2022Applied Therapeutics Inc.: Entry into a Material Definitive Agreement, Financial Statemen..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Applied Therapeutics, Inc.(NasdaqGM:APLT) dropped fr..
2022Top Midday Decliners
2022Wall Street Set for Narrow Gains as Traders Await More Powell Comments
2022Applied Therapeutics, Inc. - Announces Public Offering of Common Stock and Warrants
2022Applied Therapeutics, Inc. - Announces Pricing of $30 Million Public Offering of Common..
2022Top Premarket Decliners
2022Applied Therapeutics Prices $30 Million Public Offering
2022Applied Therapeutics, Inc. Announces Pricing of $30 Million Public Offering of Common S..
2022Applied Therapeutics, Inc. Announces Pricing of $30 Million Public Offering of Common S..
2022Applied Therapeutics Plans Public Offering -- Shares Plunge in Late Hours
2022Applied Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants
2022Applied Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants
2022Top Premarket Decliners
2022Applied Therapeutics Receives Orphan Medicinal Product Designation from the EMA for AT-..
2022Applied Therapeutics Says its Galactosemia Treatment Gets European Medicines Agency Orp..
2022Applied Therapeutics Inc.: Submission of Matters to a Vote of Security Holders (form 8-K)
2022Applied Therapeutics Receives Orphan Medicinal Product Designation from the EMA for AT-..
2022Applied Therapeutics Receives Orphan Medicinal Product Designation from the Ema for AT-..
2022Applied Therapeutics to Present at the UBS Global Healthcare Conference
2022Applied Therapeutics to Present at the UBS Global Healthcare Conference
2022APPLIED THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition ..
2022Applied Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 3..
2022Applied Therapeutics Reports First Quarter 2022 Financial Results
2022Applied Therapeutics Reports First Quarter 2022 Financial Results
2022Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022..
2022Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022..
2022Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited..
2022Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited..
2022Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the Ame..
2022Applied Therapeutics: Reports Fourth Quarter and Year-end 2021 Financial Results - Form 8..
2022Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results
2022APPLIED THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
2022Applied Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31..
2022Applied Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
2022Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
2022Applied Therapeutics Supports 15th Annual Rare Disease Day
2022Applied Therapeutics: APLT Corporate Overview – February 2022
2022Applied Therapeutics Inc.: Regulation FD Disclosure, Financial Statements and Exhibits (f..
2022Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Confer..
Prossimo evento su APPLIED THERAPEUTICS, INC.